News|Articles|April 5, 2024
Digital Biomarkers Solution shows pathway to reduced clinical trial sample sizes, shorter durations
Author(s)Roche
Digital biomarkers provide a pathway to the future where clinical trial sponsors can potentially benefit from reduced trial duration and sample size. Learn more about these benefits from a simulated study.
Trending on Applied Clinical Trials Online
1
Workflow in the Age of AI
2
The AI Churn Trap in Life Sciences and How to Break It
3
ACT Brief: Inspection Readiness Throughout Lifecycle, AI Churn and Operational Discipline, and Global Trial Stakeholder Alignment
4
Real-World Evidence in Transition: CRO Adaptation to the European Health Data Space Framework
5